Cargando…
Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19
BACKGROUND: The COVID-19 pandemic is challenging healthcare systems worldwide and has placed hospitals and healthcare providers (HCPs) at the center of a global crisis. Disruptions to hospital priorities, and limitations placed on the mobility of societies, have contributed to changes in the way HCP...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372457/ https://www.ncbi.nlm.nih.gov/pubmed/36451735 http://dx.doi.org/10.1159/000525046 |
_version_ | 1784767387419017216 |
---|---|
author | Yu, Xueqing Jha, Vivekanand Nakamoto, Hidetomo |
author_facet | Yu, Xueqing Jha, Vivekanand Nakamoto, Hidetomo |
author_sort | Yu, Xueqing |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic is challenging healthcare systems worldwide and has placed hospitals and healthcare providers (HCPs) at the center of a global crisis. Disruptions to hospital priorities, and limitations placed on the mobility of societies, have contributed to changes in the way HCPs and patients view and access dialysis for kidney failure, including which dialysis modality is preferred. SUMMARY: This article explores the dialysis experience within the COVID-19 pandemic environment in the Asia Pacific region and presents evidence that peritoneal dialysis (PD) provides benefits to patients, HCPs, and health systems. As the number of people infected with COVID-19 has increased, the advantages of PD as a dialysis modality for limiting the spread of COVID-19 infection has been recognized. KEY MESSAGE: The utility of PD has been demonstrated during the COVID-19 pandemic; thus, ensuring that the usage of PD is maintained and increased in a post-pandemic future is key. Such a scenario could enhance our ability to care for patients without interruption in circumstances of unforeseen obstacles and supports the ability of healthcare systems and patients to overcome barriers to dialysis access. |
format | Online Article Text |
id | pubmed-9372457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-93724572022-08-12 Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 Yu, Xueqing Jha, Vivekanand Nakamoto, Hidetomo Kidney Dis (Basel) Review Article BACKGROUND: The COVID-19 pandemic is challenging healthcare systems worldwide and has placed hospitals and healthcare providers (HCPs) at the center of a global crisis. Disruptions to hospital priorities, and limitations placed on the mobility of societies, have contributed to changes in the way HCPs and patients view and access dialysis for kidney failure, including which dialysis modality is preferred. SUMMARY: This article explores the dialysis experience within the COVID-19 pandemic environment in the Asia Pacific region and presents evidence that peritoneal dialysis (PD) provides benefits to patients, HCPs, and health systems. As the number of people infected with COVID-19 has increased, the advantages of PD as a dialysis modality for limiting the spread of COVID-19 infection has been recognized. KEY MESSAGE: The utility of PD has been demonstrated during the COVID-19 pandemic; thus, ensuring that the usage of PD is maintained and increased in a post-pandemic future is key. Such a scenario could enhance our ability to care for patients without interruption in circumstances of unforeseen obstacles and supports the ability of healthcare systems and patients to overcome barriers to dialysis access. S. Karger AG 2022-06-15 /pmc/articles/PMC9372457/ /pubmed/36451735 http://dx.doi.org/10.1159/000525046 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Review Article Yu, Xueqing Jha, Vivekanand Nakamoto, Hidetomo Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 |
title | Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 |
title_full | Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 |
title_fullStr | Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 |
title_full_unstemmed | Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 |
title_short | Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19 |
title_sort | should more patients with kidney failure bring treatment home? what we have learned from covid-19 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372457/ https://www.ncbi.nlm.nih.gov/pubmed/36451735 http://dx.doi.org/10.1159/000525046 |
work_keys_str_mv | AT yuxueqing shouldmorepatientswithkidneyfailurebringtreatmenthomewhatwehavelearnedfromcovid19 AT jhavivekanand shouldmorepatientswithkidneyfailurebringtreatmenthomewhatwehavelearnedfromcovid19 AT nakamotohidetomo shouldmorepatientswithkidneyfailurebringtreatmenthomewhatwehavelearnedfromcovid19 |